20927-49-5 Usage
Benzaldehyde derivative
2-(2-nitro-4-trifluoro-methylphenoxy)benzaldehyde is derived from benzaldehyde, which is a basic structure consisting of a benzene ring with a formyl group (-CHO) attached to it.
Nitro group attachment
The compound has a nitro group (-NO2) attached to the phenoxy ring, which is known for its reactivity and can be involved in various chemical reactions.
Trifluoro-methyl group attachment
The compound also has a trifluoro-methyl group (-CF3) attached to the phenoxy ring, which is an electron-withdrawing group that can influence the reactivity and properties of the compound.
Phenoxy ring
The compound contains a phenoxy ring, which is a benzene ring with an ether group (-O-) attached to it, providing a structural basis for the compound.
Organic synthesis
2-(2-nitro-4-trifluoro-methylphenoxy)benzaldehyde is often used in organic synthesis, meaning it can be used as a starting material or intermediate to produce other compounds.
Building block for other compounds
Due to its unique structure, this chemical serves as a building block for the production of other compounds, which can have various applications.
Potential applications in pharmaceuticals
The compound may have applications in the pharmaceutical industry, as its unique structure and properties can be utilized to develop new drugs.
Potential applications in agrochemicals
Similarly, 2-(2-nitro-4-trifluoro-methylphenoxy)benzaldehyde may be used in the development of agrochemicals, such as pesticides and herbicides, due to its unique properties.
Potential applications in materials science
The compound's unique structure and properties may also make it useful in materials science, for example, in the development of new materials with specific characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 20927-49-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,2 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20927-49:
(7*2)+(6*0)+(5*9)+(4*2)+(3*7)+(2*4)+(1*9)=105
105 % 10 = 5
So 20927-49-5 is a valid CAS Registry Number.
20927-49-5Relevant academic research and scientific papers
Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
-
, (2008/06/13)
The present invention provides substituted dibenzoxazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for the treatment of prostaglandin E2 -mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal, and a method for treating prostaglandin E2 -mediated diseases in an animal, comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
1-,2-,3-,4-,5-,6-,7-,8- AND/OR 9 SUBSTITUTED DIBENZOXAZEPINE COMPOUDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PAIN
-
, (2008/06/13)
The present invention provides substituted dibenzoxazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain
-
, (2008/06/13)
The present invention provides substituted dibenzoxazepine compounds of Formula I: STR1 wherein X is STR2 which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
